Hypotension and Hypoglycaemic Incidence Among End-Stage Renal Disease (ESRD) Patients During Haemodialysis Procedures
Introduction: hypotension and hypoglycaemic are complications that frequently occur in hemodialysis of End Stage Renal Disease (ESRD) patients which can increase mortality. [1-2] The prevalence of intradialytic hypotension was 18 years old, undergoing hemodialysis routine, taking antihypertensive or...
Gespeichert in:
| Veröffentlicht in: | Drug safety 2023-11, Vol.46 (11), p.1251-1252 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1252 |
|---|---|
| container_issue | 11 |
| container_start_page | 1251 |
| container_title | Drug safety |
| container_volume | 46 |
| creator | Rahmawati, F Patria, D C E Nugraheni, Y N |
| description | Introduction: hypotension and hypoglycaemic are complications that frequently occur in hemodialysis of End Stage Renal Disease (ESRD) patients which can increase mortality. [1-2] The prevalence of intradialytic hypotension was 18 years old, undergoing hemodialysis routine, taking antihypertensive or/and antidiabetic drugs, and being willing to be interviewed. Adverse effect hypotension if systolic blood pressure after hemodialysis is |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2890077148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2890077148</sourcerecordid><originalsourceid>FETCH-proquest_journals_28900771483</originalsourceid><addsrcrecordid>eNqNjUFqwzAQRUVpoG7SOwx00ywMkuvE9rLULs4uJN0HIU2MgjNKNdLCt68LOUBXjw-P_x5EplTV5Kopi0eRSaXKfNOo7ZN4Zr5IKetiW2ci9dPNRyR2nkCThb89jJPReHUGdmScRTIIH1dPA3Rk82PUA8IBSY_QOkbNCG_d8dCuYa-jQ4oMbQpu1vv5xVunx4kdwz54gzYF5JVYnPXI-HLnUrx-dd-ffX4L_ichx9PFpzAH-FTUjZRVpcr6_X_WLzo_TTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2890077148</pqid></control><display><type>article</type><title>Hypotension and Hypoglycaemic Incidence Among End-Stage Renal Disease (ESRD) Patients During Haemodialysis Procedures</title><source>SpringerLink Journals - AutoHoldings</source><creator>Rahmawati, F ; Patria, D C E ; Nugraheni, Y N</creator><creatorcontrib>Rahmawati, F ; Patria, D C E ; Nugraheni, Y N</creatorcontrib><description>Introduction: hypotension and hypoglycaemic are complications that frequently occur in hemodialysis of End Stage Renal Disease (ESRD) patients which can increase mortality. [1-2] The prevalence of intradialytic hypotension was <12% while the incidence of hypoglycemia in patients with chronic renal failure with diabetes who underwent hemodialysis was 52.9%. [3-4] To avoid these side effects, information is needed regarding the appropriate time to use antihypertensive and antidiabetic drugs in patients on the day of hemodialysis. Research on this matter has not been carried out in Indonesia. Aim: This study aims to determine a profile of the time use of antihypertensive and antidiabetic and identify the incidence of hypotension and hypoglycaemic effect in ESRD patients undergoing hemodialysis. Methods: the study used an observational cross-sectional method conducted at Installation Hemodialysis RSUP Dr. Soeradji Tirtonegoro Klaten and Purbalingga Hospital in January to March 2023. Data collection was done prospectively using the accidental sampling method. The samples used in this study were 101 patients who met the inclusion criteria with 225 total hemodialysis sessions. The inclusion criteria were >18 years old, undergoing hemodialysis routine, taking antihypertensive or/and antidiabetic drugs, and being willing to be interviewed. Adverse effect hypotension if systolic blood pressure after hemodialysis is <100 mmHg and hypoglycemia if blood glucose levels after hemodialysis <70 mg/dL. Data analysis was carried out descriptively based on data from medical records and the results of interviews with patients. Results: the results showed that the use of antihypertensive and/or antidiabetic drugs was mostly taken before hemodialysis. Hypotension occurred in two (2 %) patients, while hypoglycemia occurred in one (1%) patient. These patients consume antihypertensive and antidiabetic before the hemodialysis session. Blood pressure decreased after hemodialysis, the mean systolic and diastolic blood pressure in pre and post hemodialysis respectively 157.65 vs 148.84 mmHg and 83.57 vs 81.39 mmHg. The average random blood sugar after hemodialysis is 143.56 mg/dL. Other adverse events mainly detected during hemodialysis were headache, followed by nausea, and muscle cramps. Conclusions: the incidence of hypotension and hypoglycemia is relatively low. Although many factors have contributed to that event, it is necessary to provide appropriate information to patients about the time to use antihypertensives and antidiabetics during hemodialysis to avoid adverse effects.</description><identifier>ISSN: 0114-5916</identifier><identifier>EISSN: 1179-1942</identifier><language>eng</language><publisher>Auckland: Springer Nature B.V</publisher><subject>Antidiabetics ; Antihypertensives ; Blood glucose ; Blood levels ; Blood pressure ; Complications ; Cramps ; Criteria ; Data analysis ; Data collection ; Diabetes mellitus ; Drugs ; End-stage renal disease ; Hemodialysis ; Hypoglycemia ; Hypotension ; Kidney diseases ; Medical records ; Patients ; Renal failure ; Sampling methods ; Side effects ; Time of use</subject><ispartof>Drug safety, 2023-11, Vol.46 (11), p.1251-1252</ispartof><rights>Copyright Springer Nature B.V. Nov 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Rahmawati, F</creatorcontrib><creatorcontrib>Patria, D C E</creatorcontrib><creatorcontrib>Nugraheni, Y N</creatorcontrib><title>Hypotension and Hypoglycaemic Incidence Among End-Stage Renal Disease (ESRD) Patients During Haemodialysis Procedures</title><title>Drug safety</title><description>Introduction: hypotension and hypoglycaemic are complications that frequently occur in hemodialysis of End Stage Renal Disease (ESRD) patients which can increase mortality. [1-2] The prevalence of intradialytic hypotension was <12% while the incidence of hypoglycemia in patients with chronic renal failure with diabetes who underwent hemodialysis was 52.9%. [3-4] To avoid these side effects, information is needed regarding the appropriate time to use antihypertensive and antidiabetic drugs in patients on the day of hemodialysis. Research on this matter has not been carried out in Indonesia. Aim: This study aims to determine a profile of the time use of antihypertensive and antidiabetic and identify the incidence of hypotension and hypoglycaemic effect in ESRD patients undergoing hemodialysis. Methods: the study used an observational cross-sectional method conducted at Installation Hemodialysis RSUP Dr. Soeradji Tirtonegoro Klaten and Purbalingga Hospital in January to March 2023. Data collection was done prospectively using the accidental sampling method. The samples used in this study were 101 patients who met the inclusion criteria with 225 total hemodialysis sessions. The inclusion criteria were >18 years old, undergoing hemodialysis routine, taking antihypertensive or/and antidiabetic drugs, and being willing to be interviewed. Adverse effect hypotension if systolic blood pressure after hemodialysis is <100 mmHg and hypoglycemia if blood glucose levels after hemodialysis <70 mg/dL. Data analysis was carried out descriptively based on data from medical records and the results of interviews with patients. Results: the results showed that the use of antihypertensive and/or antidiabetic drugs was mostly taken before hemodialysis. Hypotension occurred in two (2 %) patients, while hypoglycemia occurred in one (1%) patient. These patients consume antihypertensive and antidiabetic before the hemodialysis session. Blood pressure decreased after hemodialysis, the mean systolic and diastolic blood pressure in pre and post hemodialysis respectively 157.65 vs 148.84 mmHg and 83.57 vs 81.39 mmHg. The average random blood sugar after hemodialysis is 143.56 mg/dL. Other adverse events mainly detected during hemodialysis were headache, followed by nausea, and muscle cramps. Conclusions: the incidence of hypotension and hypoglycemia is relatively low. Although many factors have contributed to that event, it is necessary to provide appropriate information to patients about the time to use antihypertensives and antidiabetics during hemodialysis to avoid adverse effects.</description><subject>Antidiabetics</subject><subject>Antihypertensives</subject><subject>Blood glucose</subject><subject>Blood levels</subject><subject>Blood pressure</subject><subject>Complications</subject><subject>Cramps</subject><subject>Criteria</subject><subject>Data analysis</subject><subject>Data collection</subject><subject>Diabetes mellitus</subject><subject>Drugs</subject><subject>End-stage renal disease</subject><subject>Hemodialysis</subject><subject>Hypoglycemia</subject><subject>Hypotension</subject><subject>Kidney diseases</subject><subject>Medical records</subject><subject>Patients</subject><subject>Renal failure</subject><subject>Sampling methods</subject><subject>Side effects</subject><subject>Time of use</subject><issn>0114-5916</issn><issn>1179-1942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNjUFqwzAQRUVpoG7SOwx00ywMkuvE9rLULs4uJN0HIU2MgjNKNdLCt68LOUBXjw-P_x5EplTV5Kopi0eRSaXKfNOo7ZN4Zr5IKetiW2ci9dPNRyR2nkCThb89jJPReHUGdmScRTIIH1dPA3Rk82PUA8IBSY_QOkbNCG_d8dCuYa-jQ4oMbQpu1vv5xVunx4kdwz54gzYF5JVYnPXI-HLnUrx-dd-ffX4L_ichx9PFpzAH-FTUjZRVpcr6_X_WLzo_TTA</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Rahmawati, F</creator><creator>Patria, D C E</creator><creator>Nugraheni, Y N</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20231101</creationdate><title>Hypotension and Hypoglycaemic Incidence Among End-Stage Renal Disease (ESRD) Patients During Haemodialysis Procedures</title><author>Rahmawati, F ; Patria, D C E ; Nugraheni, Y N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_28900771483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antidiabetics</topic><topic>Antihypertensives</topic><topic>Blood glucose</topic><topic>Blood levels</topic><topic>Blood pressure</topic><topic>Complications</topic><topic>Cramps</topic><topic>Criteria</topic><topic>Data analysis</topic><topic>Data collection</topic><topic>Diabetes mellitus</topic><topic>Drugs</topic><topic>End-stage renal disease</topic><topic>Hemodialysis</topic><topic>Hypoglycemia</topic><topic>Hypotension</topic><topic>Kidney diseases</topic><topic>Medical records</topic><topic>Patients</topic><topic>Renal failure</topic><topic>Sampling methods</topic><topic>Side effects</topic><topic>Time of use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahmawati, F</creatorcontrib><creatorcontrib>Patria, D C E</creatorcontrib><creatorcontrib>Nugraheni, Y N</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahmawati, F</au><au>Patria, D C E</au><au>Nugraheni, Y N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypotension and Hypoglycaemic Incidence Among End-Stage Renal Disease (ESRD) Patients During Haemodialysis Procedures</atitle><jtitle>Drug safety</jtitle><date>2023-11-01</date><risdate>2023</risdate><volume>46</volume><issue>11</issue><spage>1251</spage><epage>1252</epage><pages>1251-1252</pages><issn>0114-5916</issn><eissn>1179-1942</eissn><abstract>Introduction: hypotension and hypoglycaemic are complications that frequently occur in hemodialysis of End Stage Renal Disease (ESRD) patients which can increase mortality. [1-2] The prevalence of intradialytic hypotension was <12% while the incidence of hypoglycemia in patients with chronic renal failure with diabetes who underwent hemodialysis was 52.9%. [3-4] To avoid these side effects, information is needed regarding the appropriate time to use antihypertensive and antidiabetic drugs in patients on the day of hemodialysis. Research on this matter has not been carried out in Indonesia. Aim: This study aims to determine a profile of the time use of antihypertensive and antidiabetic and identify the incidence of hypotension and hypoglycaemic effect in ESRD patients undergoing hemodialysis. Methods: the study used an observational cross-sectional method conducted at Installation Hemodialysis RSUP Dr. Soeradji Tirtonegoro Klaten and Purbalingga Hospital in January to March 2023. Data collection was done prospectively using the accidental sampling method. The samples used in this study were 101 patients who met the inclusion criteria with 225 total hemodialysis sessions. The inclusion criteria were >18 years old, undergoing hemodialysis routine, taking antihypertensive or/and antidiabetic drugs, and being willing to be interviewed. Adverse effect hypotension if systolic blood pressure after hemodialysis is <100 mmHg and hypoglycemia if blood glucose levels after hemodialysis <70 mg/dL. Data analysis was carried out descriptively based on data from medical records and the results of interviews with patients. Results: the results showed that the use of antihypertensive and/or antidiabetic drugs was mostly taken before hemodialysis. Hypotension occurred in two (2 %) patients, while hypoglycemia occurred in one (1%) patient. These patients consume antihypertensive and antidiabetic before the hemodialysis session. Blood pressure decreased after hemodialysis, the mean systolic and diastolic blood pressure in pre and post hemodialysis respectively 157.65 vs 148.84 mmHg and 83.57 vs 81.39 mmHg. The average random blood sugar after hemodialysis is 143.56 mg/dL. Other adverse events mainly detected during hemodialysis were headache, followed by nausea, and muscle cramps. Conclusions: the incidence of hypotension and hypoglycemia is relatively low. Although many factors have contributed to that event, it is necessary to provide appropriate information to patients about the time to use antihypertensives and antidiabetics during hemodialysis to avoid adverse effects.</abstract><cop>Auckland</cop><pub>Springer Nature B.V</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0114-5916 |
| ispartof | Drug safety, 2023-11, Vol.46 (11), p.1251-1252 |
| issn | 0114-5916 1179-1942 |
| language | eng |
| recordid | cdi_proquest_journals_2890077148 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Antidiabetics Antihypertensives Blood glucose Blood levels Blood pressure Complications Cramps Criteria Data analysis Data collection Diabetes mellitus Drugs End-stage renal disease Hemodialysis Hypoglycemia Hypotension Kidney diseases Medical records Patients Renal failure Sampling methods Side effects Time of use |
| title | Hypotension and Hypoglycaemic Incidence Among End-Stage Renal Disease (ESRD) Patients During Haemodialysis Procedures |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A49%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypotension%20and%20Hypoglycaemic%20Incidence%20Among%20End-Stage%20Renal%20Disease%20(ESRD)%20Patients%20During%20Haemodialysis%20Procedures&rft.jtitle=Drug%20safety&rft.au=Rahmawati,%20F&rft.date=2023-11-01&rft.volume=46&rft.issue=11&rft.spage=1251&rft.epage=1252&rft.pages=1251-1252&rft.issn=0114-5916&rft.eissn=1179-1942&rft_id=info:doi/&rft_dat=%3Cproquest%3E2890077148%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2890077148&rft_id=info:pmid/&rfr_iscdi=true |